Elevated transaminases

From Wikipedia, the free encyclopedia
  (Redirected from Transaminitis)
Jump to: navigation, search
Elevated transaminases
Classification and external resources
Alanine amino transférase.png
Alanine transaminase is one of the two transaminases measured (Aspartate transaminase is the other)
ICD-10 R74.0
ICD-9 790.4
DiseasesDB 14820 15393

In medicine, the presence of elevated transaminases, commonly the transaminases alanine transaminase (ALT) and aspartate transaminase (AST), may be an indicator of liver damage.[1] Other terms employed include transaminasemia[2] and transaminitis, although some sources consider the latter pathologically meaningless.[3] Normal ranges for both ALT and AST are 8-40 U/L with mild transaminesemia noted to the upward numerical limit of 250 U/L. Drug-induced increases such as that found with the use of anti-tuberculosis agents such as isoniazid are limited typically to below 100 U/L for either ALT or AST. Cirrhosis of the liver or fulminant liver failure secondary to hepatitis commonly reach values for both ALT and AST in the >1000+ U/L range. Elevated transaminases that persist less than six months are termed 'acute' in nature, and those values that persist for six months or more are termed 'chronic' in nature.

Pathophysiology[edit]

The liver has transaminases to synthesize and break down amino acids and to convert energy storage molecules. The concentrations of these transaminases in the serum (the non-cellular portion of blood, also called plasma) are normally low. However, if the liver is damaged, the liver cell (hepatocyte) membrane becomes more permeable and some of the enzymes leak out into the blood circulation.

The two transaminases commonly measured are alanine transaminase (ALT) and aspartate transaminase (AST).[4] These levels previously were called serum glutamate-pyruvate transaminase (SGPT) and serum glutamate-oxaloacetate transaminase (SGOT).

Elevated levels are sensitive for liver injury, meaning that they are likely to be present if there is injury. However, they may also be elevated in other conditions.

ALT is usually found only in the liver. AST is most commonly found in the liver, but also in significant amounts in heart (cardiac) and skeletal muscle.

Measurement of ALT and AST were used in diagnosing heart attacks, although they have been replaced by newer enzyme and protein tests that are more specific for cardiac damage.

Possible causes for high ALT levels are liver inflammation (hepatitis A, B, C, Infectious mononuceosis, acute viral fever, alcohol, pancreatic disorder), injury to muscles (trauma, myocardial infarction, congestive heart failure, acute kidney failure), and many toxins and drugs.

Role in diagnosis[edit]

In general, any damage to the liver will cause medium elevations in these transaminases (usually called liver enzymes, though of course they are not the only enzymes in the liver), but diagnosis requires synthesis of many pieces of information, including the patient's history, physical examination, and possibly imaging or other laboratory examinations. However, very high elevations of the transaminases suggests severe liver damage, such as viral hepatitis, liver injury from lack of blood flow, or injury from drugs or toxins. Most disease processes cause ALT to rise higher than AST; AST levels double or triple that of ALT are consistent with alcoholic liver disease.

Levels over 1000 can be associated with ischemic hepatitis.[5]

See also[edit]

References[edit]

  1. ^ Giboney PT (March 2005). "Mildly elevated liver transaminase levels in the asymptomatic patient". Am Fam Physician 71 (6): 1105–10. PMID 15791889. 
  2. ^ "Transaminasemia: semantic confusion of a clinical dilemma". Calif Med 114 (6): 45–7. June 1971. PMC 1501958. PMID 5578107. 
  3. ^ Maddrey, Willis C.; Schiff, Eugene R.; Sorrell, Michael F. (2007). Schiff's diseases of the liver. Hagerstwon, MD: Lippincott Williams & Wilkins. p. 924. ISBN 0-7817-6040-2. 
  4. ^ "Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient - March 15, 2005 - American Family Physician". Retrieved 2009-07-11. 
  5. ^ Raurich JM, Pérez O, Llompart-Pou JA, Ibáñez J, Ayestarán I, Pérez-Bárcena J (July 2009). "Incidence and outcome of ischemic hepatitis complicating septic shock". Hepatol. Res. 39 (7): 700–5. doi:10.1111/j.1872-034X.2009.00501.x. PMID 19473435.